Cardio-respiratory Events and Inflammatory Response After Primary Immunization in Preterm Infants
NCT02726178 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 56
Last updated 2018-05-17
Summary
Background: Inflammation may depress respiration in neonates. The aim of this study was to establish a link between post-immunization inflammation and cardio-respiratory events (CRE).
Methods: Randomized double-blind controlled study of infants born \<32 weeks gestation receiving the 2 months vaccine. Infants were randomized into an ibuprofen treatment group and a placebo control group. C-reactive protein (CRP) and prostaglandins E2 (PgE2) levels were assessed before and after immunization. CRE were recorded for 72 hours. Heart rate variability (HRV) was assessed by polysomnography.
Conditions
- Complication Due to Immunization
Interventions
- DRUG
-
Advil® Pediatric drops for infants
Study the effect of inhibition of prostaglandins with ibuprofen vs placebo administration on cardio respiratory events in preterms infants
- DRUG
-
Study the effect of inhibition of prostaglandins with ibuprofen vs placebo administration on cardio respiratory events in preterms infants
Sponsors & Collaborators
-
Rennes University Hospital
collaborator OTHER -
St. Justine's Hospital
lead OTHER
Principal Investigators
-
Anne Monique Nuyt, MD · Ste-Justine's hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 7 Weeks
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-02-28
- Primary Completion
- 2011-03-31
- Completion
- 2012-04-30
More Related Trials
-
Safety of Fluconazole Treatment of Premature and Full-term Newborn Infants
NCT02079298 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Pre-emptive Analgesia on the Postoperative Pain in Children Undergoing Pediatric Stomatology Day Surgeries
NCT05878262 ·Status: COMPLETED ·Phase: NA
-
Oral Versus Rectal Ibuprofen for Fever in Young Children - a Randomized Control Study.
NCT00729976 ·Status: UNKNOWN ·Phase: PHASE4
-
Randomized Controlled Trial to Evaluate the Safety and Efficacy of Acetaminophen in Preterm Infants Used in Combination With Ibuprofen for Closure of the Ductus Arteriosus
NCT03701074 ·Status: TERMINATED ·Phase: PHASE2
-
Comparison of Oral and Intravenous Ibuprofen for PDA Treatment in Premature Infants
NCT01149564 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Safety and Pharmacokinetic Study of Intravenous Ibuprofen in Pediatric Patients
NCT02583399 ·Status: COMPLETED ·Phase: PHASE4
-
Combination of Acetaminophen and Ibuprofen in the Management of Patent Ductus Arteriosus
NCT03103022 ·Status: COMPLETED ·Phase: PHASE1
-
High-dose Ibuprofen for Patent Ductus Arteriosus (PDA) in Preterm Infant
NCT01243996 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Adding Paracetamol to Ibuprofen for Treatment of Patent Ductus Arteriosus in Preterm Infants
NCT02002741 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Comparative Study of Efficacy and Safety of Oral Ibuprofen and Intravenous Ibuprofen in Closure of Patent Ductus Arteriosus in Very Low Birth Weight Infants
NCT00642330 ·Status: COMPLETED ·Phase: PHASE4
-
Paracetamol in Patent Ductus Arteriosus
NCT02422966 ·Status: COMPLETED ·Phase: PHASE2
-
Early Versus Late Use of Ibuprofen for Patent Ductus Arteriosus (PDA) Closure
NCT00833365 ·Status: TERMINATED ·Phase: NA
-
Paracetamol Versus Ibuprofen for PDA Closure
NCT03265782 ·Status: UNKNOWN ·Phase: PHASE4
-
IV Acetaminophen and Patent Ductus Arteriosus
NCT03008876 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Study of Ibuprofen l-Lysine Solution in Premature Infants for Treatment of PDA
NCT00440804 ·Status: COMPLETED ·Phase: PHASE3
-
Relation Between Prostaglandin E2 Metabolite Levels and the Development of Hemodynamically Significant Patent Ductus Arteriosus in Preterm Neonates
NCT07338370 ·Status: RECRUITING
-
Co-administration of Acetaminophen With Ibuprofen to Improve Duct-Related Outcomes in Extremely Premature Infants
NCT05340582 ·Status: RECRUITING ·Phase: PHASE2
-
Paracetamol vs Ibuprofen for PDA Closure in Preterm Infants.
NCT02056223 ·Status: SUSPENDED ·Phase: PHASE2/PHASE3
-
Pediatric Non-Steroidal Anti-Inflammatory Drugs (NSAID) Allergy Study
NCT07034066 ·Status: COMPLETED
-
Comparing Ibuprofen And Indomethacin For The Treatment Of The Patent Ductus Arteriosus in Very Premature Babies
NCT00470743 ·Status: WITHDRAWN ·Phase: PHASE4
-
Efficacy and Safety of Oral Versus Intravenous Ibuprofen for PDA Treatment in ELBW Infants
NCT01261117 ·Status: COMPLETED ·Phase: NA
-
Ketorolac in Postoperative Infants: Pharmacokinetics and Safety
NCT01260883 ·Status: COMPLETED ·Phase: PHASE3
-
Investigating the Safety of Post-surgical Analgesics in Children With Obstructive Sleep Apnea
NCT01680939 ·Status: UNKNOWN ·Phase: PHASE3
-
Ibuprofen vs. Continuous Indomethacin in the Treatment of PDA
NCT00485160 ·Status: COMPLETED ·Phase: PHASE3
-
Precision Dosing of Oral Ibuprofen for PDA, A Pilot RCT
NCT07143201 ·Status: RECRUITING ·Phase: PHASE2